Calls of the Day: UnitedHealth, Berkshire Hathaway and Cleveland-Cliffs
The Investment Committee discuss the latest Calls of the Day.
Fiscal Year: January - December
UnitedHealth Group Incorporated (UNH), listed on the NYSE, has a market capitalization of $. As of Aug 19, 2025, the stock is trading at $308.49 per share, offering investors a clear view of its current market value. UnitedHealth Group Incorporated is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 13.35, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. UnitedHealth Group Incorporated also offers a dividend yield of 2.87%, making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that UnitedHealth Group Incorporated (UNH) may be undervalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for UnitedHealth Group Incorporated is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for UnitedHealth Group Incorporated, Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for UnitedHealth Group Incorporated is 11.12, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, UnitedHealth Group Incorporated (UNH) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether UnitedHealth Group Incorporated (UNH) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be undervalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of UnitedHealth Group Incorporated (UNH) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of UnitedHealth Group Incorporated. To access the full SS Score, consider upgrading your subscription.
UnitedHealth Group Incorporated is a significant player in the industry sector, with a market capitalization of $ and a competitive P/E ratio of 13.35. Investors should compare these metrics with industry peers to gauge whether UnitedHealth Group Incorporated is outperforming or underperforming within its sector.
The Investment Committee discuss the latest Calls of the Day.
On Friday, high-profile investors Michael Burry and Warren Buffett took positions in UnitedHealth Group Inc. UNH. Warren Buffett's fund bought little more than 5 million shares, and Burry disclosed in...
Investor risk sentiment paused at the start of the week, as markets awaited details expected to emerge later when President Donald Trump meets with Ukrainian President Volodymyr Zelenskyy and European...
Warren Buffett's Berkshire Hathaway revealed a $1.6 billion investment in UnitedHealth Group (NYSE: UNH) on August 15, 2025, causing the stock to rise by 11% in its best trading day since 2020. This i...
Enterprise software is not facing extinction from generative AI; disruption is real, but incumbents are adapting and leveraging AI themselves. Continuity, institutional knowledge, and platform ecosyst...
Shares of some of UnitedHealth's peers got a bump in the wake of Berkshire's investment in the healthcare giant, and they all look cheaper based on price relative to expected earnings.
Berkshire Hathaway's $1.6 billion stake in UnitedHealth Group is helping to lift the Dow Jones Industrial Average to a new record as investors pile into healthcare sector funds.
Markets muscled yet another winning week, led by a 3% rally from the RUT. The A.I. trade continued to dominate headlines, starting with Monday's announcement that Nvidia (NVDA) and AMD Inc. (AMD) will...
Berkshire Hathaway's UnitedHealth Group Incorporated share purchase signals confidence in a sector where it has deep operational expertise. UnitedHealth remains systemically vital; no one, or possibly...
The 'Fast Money' traders discuss if UnitedHealth is poised to make a comeback.
U.S. stocks logged weekly gains, the major indexes finishing Friday with mixed results heading into the weekend, as the Michigan Consumer Sentiment Index showed declining confidence in the state of th...
A vote of confidence by Warren Buffett's Berkshire Hathaway delivered the Dow laggard its best day since 2020.
Value-hunters with big stakes in a particular component kept one of the main U.S. equity indexes in positive territory.
“Street sense” is all about making bold calls: Sometimes you nail them, and sometimes you learn from them.
Berkshire Hathaway's $1.6 billion stake in UnitedHealth Group is helping to lift the Dow Jones Industrial Average to a new record as investors pile into healthcare sector funds.
UnitedHealth Group Inc UNH has transformed from Wall Street darling to crisis headline. Yet ironically, a who's-who of investors doubled down on the stock in Q2 even as volatility reigns.
Major tech-heavy indices edged lower from record highs by midday Friday in New York, as investors adopted a cautious stance ahead of the Trump-Putin meeting and after data showed a dip in consumer con...
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest buy. The Investment Committee debate her trade as well as Berkshire Hathaway taking a stake in the beleaguered ins...
Shares in the troubled private health insurer UnitedHealth Group (NYSE: UNH) are currently seeing their best trading day in months. As of the time of this writing, UNH shares are up nearly 11.8% to $3...
The Dow Jones Industrial Average opened at its first all-time high of the year on Friday as shares of health care giant UnitedHealth Group (UNH) soared.
Berkshire Hathaway's $1B+ investment in UnitedHealth signals confidence in the company despite recent share price declines and profitability headwinds. UnitedHealth's Q2 revenue grew 13%, but profit m...
UnitedHealth Group (UNH) shares surged Friday after Warren Buffett's Berkshire Hathaway (BRK.A, BRK.B) revealed a stake in the embattled healthcare giant.
U.S. equities were mixed at midday as a report on retail sales showed consumers are continuing to spend. The Dow Jones Industrial Average was up slightly, while the S&P 500 and Nasdaq fell.
AJ Rice, UBS analyst, joins 'Money Movers' to discuss UnitedHealth shares surging on Berkshire Hathaway stake in the stock.
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
Year | FCF Estimate | % | # Analysts |
---|---|---|---|
2025 | 19.30B | -6.78% | Est @-6.8% |
2026 | 17.90B | -7.28% | Analyst x3 |
2027 | 20.84B | 16.43% | Analyst x2 |
2028 | 24.00B | 15.20% | Analyst x1 |
2029 | 27.60B | 14.96% | Analyst x1 |
2030 | 29.64B | 7.42% | Est @7.4% |
2031 | 31.39B | 5.89% | Est @5.9% |
2032 | 32.90B | 4.81% | Est @4.8% |
2033 | 34.24B | 4.07% | Est @4.1% |
2034 | 35.37B | 3.30% | Est @3.3% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
Year | FCF | Discount Factor | PV of Future FCF |
---|---|---|---|
2023A | 25.68B | 1.00 | 25.68B |
2024A | 20.71B | 1.00 | 20.71B |
2025E | 19.30B | 1.07 | 17.96B |
2026E | 17.90B | 1.15 | 15.49B |
2027E | 20.84B | 1.24 | 16.79B |
2028E | 24.00B | 1.33 | 17.99B |
2029E | 27.60B | 1.43 | 19.25B |
2030E | 29.64B | 1.54 | 19.24B |
2031E | 31.39B | 1.66 | 18.96B |
2032E | 32.90B | 1.78 | 18.49B |
2033E | 34.24B | 1.91 | 17.90B |
2034E | 35.37B | 2.06 | 17.21B |
Terminal | 729.39B | 2.06 | 354.87B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.